The last 5 years have seen the emergence of efficacious peptide-based therapies for obesity treatment that target glucagon-like peptide-1 receptor (GLP-1R), either selectively or via co-activation with related receptors, such as the glucose-dependent insulinotropic polypeptide and/or glucagon receptors 1
BPC-157 is managing the consequences of inflammation
Moisturizes dehydrated skin with Hyaluronic Acid and Beta Glucan
Melanotan II is up to 1000 times more potent than endogenous -MSH, binding to the bodys melanocortin receptors in varying degrees, exerting varied effects
The use of novel carriers such as liposomes, nanoparticles, sphingosomes, emulsomes, ethosomes, transferosomes, proniosomes and phytosomes has successfully improved targeted delivery and therapeutic efficacy of poorly aqueous soluble plant drugs [84, 85]
sptin_nutrabio-super-carb-30-servings 3